Knuff & Co’s AstraZeneca AZN Stock Holding History

Knuff & Co’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Buy	+1,050	New	+$197K	0.05%	99
2024 Q1	–	Sell	-175	Closed	-$23.6K	–	126
2023 Q4	$23.6K	Buy	+175	New	+$22.8K	0.01%	116
2021 Q1	–	Sell	-1,213	Closed	-$121K	–	153
2020 Q4	$121K	Hold	1,213	–	–	0.05%	91
2020 Q3	$133K	Buy	1,213 +38	+3%	+$4.23K	0.06%	83
2020 Q2	$124K	Buy	1,175 +75	+7%	+$7.75K	0.07%	80
2020 Q1	$98K	Hold	1,100	–	–	0.07%	86
2019 Q4	$110K	Buy	+1,100	New	+$104K	0.07%	85

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Knuff & Co's AZN Position: Q2 2026 in Review

Knuff & Co opened a new position in AstraZeneca (AZN) in Q2 2026: 1,050 shares worth $199K. The stake represents 0.05% of the portfolio and ranks #99 among its holdings. This is a return to the name: Knuff & Co previously reported a position in AZN as recently as Q4 2023.

Knuff & Co first reported a position in AZN in Q4 2019 and has held it in 7 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Knuff & Co held 1,050 shares of AstraZeneca worth $199K as of Q2 2026.
AstraZeneca was a new Knuff & Co position in Q2 2026.
AstraZeneca made up 0.05% of Knuff & Co's portfolio in Q2 2026, its #99 holding.
Knuff & Co first reported a position in AstraZeneca in Q4 2019 and has held it in 7 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.